ReleaseWire

Highly educated Ellie Behrooznia, Pharm. D and Erick Khaimoff, Pharm. D lead the Los Angeles Compounding Pharmacy team of experienced pharmacists, technicians, and chemists. As a result, this great team guarantees to meet your expectations. At the Los Angeles Compounding Pharmacy, every visitor is treated well. No visitor has to worry about leaving the pharmacy with his or her questions unanswered.

The Treedom Group, a Thailand-based Oud Oil manufacturer and supplier to the global fragrance markets is highlighting an interesting study into the precious oil's potential breast cancer fighting properties. The Malaysian research university study revealed found concentrations of Oud oil inhibited 50% of the control cell growth, demonstrating activity against MCF-7 breast cancer cells.

With big plans in their mind, Star Discount Chemist is now set to open its new store in Narangba, Queensland, Australia. The inauguration of their new store is scheduled on 15th September 2016. Their new store will benefit the people of Narangba in getting one-of-a-kind health services at the never-seen-before prices. The range of health services they will be providing at their new outlet include medication assistance, medschecks, home delivery, diabetes management, health advice, and blood pressure checks. All these services will be provided by their team of experienced medical professionals who have deep knowledge and years of experience working in the healthcare industry.

Many pharmacies take about 30 minutes to refill or fill a prescription. At the compounding pharmacy in Santa Monica, prescriptions are filled in 10 minutes. Customers do not have to worry about trying to understand their medication on their own, because the pharmacy staff ensures to explain instructions thoroughly. The wonderful team at the compounding pharmacy in Santa Monica will happily answer any questions that customers have.

COS 2016, the 4th annual Clinical Outsourcing Strategies Symposium will be held in Brussels, Belgium on the 20th & 21st of October 2016. Sixteen prestigious professionals within the pharmaceutical industry have confirmed their speaking positions. With a capacity of 150 participants, COS will be held along with the Clinical Trial Supplies Network (CTS) – 2nd Annual Symposium on the same dates and venue.

Q BioMed Inc., a biotechnology acceleration company is pleased to report on its asset acquisition and an update on corporate development.

Medicortex Finland Oy (www.medicortex.fi), a biotechnology company developing a diagnostic kit for brain injury based on a medical breakthrough biomarker, recently was granted clearance to begin a clinical trial. The trial will consist of patients that are hospitalized due to a head injury.

BioCorRx Inc. (OTCPink:BICX) (the "Company"), developer of the BioCorRx® Recovery Program, a medication-assisted treatment (MAT) program, announced today the formation of a new subsidiary, BioCorRx Pharmaceuticals, in conjunction with the company's Development, Commercialization and License Agreement with TheraKine Ltd. for exclusive worldwide rights, licenses and sublicensing to patented and patent pending TheraKine technology for sustained release naltrexone delivery.

Clinical Trial Supplies 2nd Annual Symposium will be held in Brussels on the 20th and 21st of October 2016. CTS is a meeting dedicated in exploring Investigational Medicinal Products (IMPs) and NON-Investigational Medicinal Products (NIMPs) based on logistics, distribution, packaging, labelling and storage. Speakers include senior experts from the Top 50 Bio/Pharma companies worldwide, and high caliper colleagues from Small to Medium Size Bio/Pharma/Biotech companies globally. Brussels Clinical Trial Supply network is co-housed with the 4th Annual Clinical Outsourcing Strategies Symposium (COS 2016).

Clinical Trial Supplies 2nd Annual Symposium will be held in Brussels on the 20th and 21st of October 2016. CTS is a meeting dedicated in exploring the medical supplies required for Clinical Trials and Operations. Presented by prestigious pharmaceutical and biotechnology companies globally engaged to discussed key challenges in Clinical Trial Logistics. With capacity of 100+ attendees, CTS will be held along with the 4th Annual Clinical Outsourcing Strategies Symposium (COS 2016), sharing the same days, venue and exhibition area.

DiaMedica Inc. (the "Company") is pleased to announce that it has closed the first tranche of a non-brokered private placement previously announced on July 17, 2016. The first tranche was an investment of USD$1.0 million by Hermed Capital Healthcare Fund ("Hermed") for 5 million common shares of the Company at USD$0.20 per share. The second tranche, which will be an investment of USD$3.0 million by Hermed for 15 million common shares of the Company at USD$0.20 per share, is expected to close in the next few weeks.

Innovus Pharmaceuticals, Inc. ("Innovus Pharma") (OTCQB Venture Market:INNV), an emerging commercial stage cash flow positive pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men and women's health and respiratory diseases, today announced today that its partner Khandelwal Laboratories received the approval of the product licenses for Zestra®, Zestra Glide®, EjectDelay® and Sensum+® from the Indian FDA, The Drugs Controller General (India), and the Directorate General of Health Services to commercialize the products in India.

ABC Pharmacy of Beverly Hills is a premier Westwood compounding pharmacy. They have built an excellent reputation among their community by providing top-rated customer service for each and every one of their patients. In order to do this, the pharmacy hires only the most qualified and knowledgeable pharmacists and technicians. Erick Khaimoff, PharmD and Ellie Behrooznia, PharmD are at the head of the team. Each staff member is highly educated, well trained and experienced in the industry.

Los Angeles compounding pharmacy, ABC Compounding Pharmacy, is a full-service pharmacy that specializes in regular and compounded prescriptions. As a family-owned institution, they are able to provide a personalized experience for their patients that is unparalleled by big name pharmacies like CVS, Rite-Aid and Walgreens. Ellie Behrooznia, PharmD and Erick Khaimoff, PharmD lead the team at ABC Compounding Pharmacy. Together they have over 25 years of experience in the industry.

Innovus Pharmaceuticals, Inc., ("Innovus Pharma") www.innovuspharma.com (OTCQB:INNV) announced today it will release its second quarter 2016 financial results before the open of trading on Tuesday August 9, 2016 ahead of its 10-Q to be filed on August 15, 2016. The company will host a conference call at 4:15 p.m. EDT/1:15 p.m. PDT on the same day (August 9, 2016) to discuss the financial results and recent business developments.

Innovus Pharmaceuticals, Inc., ("Innovus Pharma") www.innovuspharma.com (OTCQB:INNV) announced today it has re-appointed PT Laras Bumi Resources ("LB Resources") as its agent for the distribution of its product Zestra® to increase Female Sexual Arousal and Desire and Satisfaction in select Asian countries. Based in Indonesia ("LB Resources") has extensive distribution in Japan, China, Indonesia and South Korea. LB Resources projects an initial ordering annual volume close to 150,000 units a year.

BioCorRx Inc. (OTCPINK:BICX) (the "Company"), developer of the BioCorRx® Recovery Program, a non-addictive, medication-assisted treatment (MAT) program used in the treatment of alcohol and opioid addiction, announced today it has signed a Development, Commercialization and License Agreement with TheraKine Ltd. effective July 28, 2016 for exclusive worldwide rights, licenses and sublicensing to patented and patent pending TheraKine technology for sustained release medication delivery. The agreement is specific to the use of the technology to treat addictions using the medication, naltrexone.

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company) www.innovuspharma.com (OTCQB:INNV), a company focusing on the commercialization of over-the-counter ("OTC") and consumer products for men's and women's health, vitality and respiratory diseases, announced today, the closing of its previously announced $3 million private financing from institutional investors.

Manzo Pharmaceuticals, Inc. (OTCPink:MNZO) announced today that the company's President, Kenneth Manzo, has received a verbal Wells Notice from the US Securities and Exchange Commission.

ABC Pharmacy of Beverly Hills is a Westwood compounding pharmacy that has continually impressed residents of Beverly Hills and Westwood. In a privately funded survey, the Westwood compounding pharmacy was recognized as top-tier compounding pharmacy. The Westwood compounding pharmacy is a family owned, local pharmacy that has provided exceptional service to its customers. Residents of Beverly Hills have commended the Westwood compounding pharmacy for quality of their service and the care of their staff.

GlobalData's clinical trial report, "Hyperuricemia Global Clinical Trials Review, H1, 2016" provides an overview of Hyperuricemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperuricemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

GlobalData's clinical trial report, "Amyloidosis Global Clinical Trials Review, H1, 2016" provides an overview of Amyloidosis clinical trials scenario. This report provides top line data relating to the clinical trials on Amyloidosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

GlobalData's clinical trial report, "Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H1, 2016" provides an overview of Bile Duct Cancer (Cholangiocarcinoma) clinical trials scenario. This report provides top line data relating to the clinical trials on Bile Duct Cancer (Cholangiocarcinoma). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

GlobalData's clinical trial report, "Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of Diffuse Large B-Cell Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Diffuse Large B-Cell Lymphoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

GlobalData's clinical trial report, "Diabetic Retinopathy Global Clinical Trials Review, H1, 2016" provides an overview of Diabetic Retinopathy clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Retinopathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.